BioMaxima Stock

BioMaxima EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of BioMaxima (BMX.WA) as of Jul 31, 2026 is 41.83. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 2,813.80 — a change of -98.51% (lower).

EV/EBIT

41.83

YoY

-98.51%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of BioMaxima is 2026 41.83 . EV/EBIT (Enterprise Value to EBIT) of BioMaxima was 2025 2,813.80 . It decreases by -98.51% lower compared to the previous year.

The BioMaxima EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2017
17.16 base
Jan 1, 2018
311.70 base
Jan 1, 2019
17.26 base
Jan 1, 2020
12.06 base
Jan 1, 2021
8.62 base
Jan 1, 2022
3.29 base
Jan 1, 2023
0.00 base
Jan 1, 2024
35.11 base
YEARPRICE-TO-EBIT
2024 35.11
2023 -
2022 3.29
2021 8.62
2020 12.06
2019 17.26
2018 311.70
2017 17.16
2016 12.69
2015 7.22
Access this data via the Eulerpool API
Get Free API Key

BioMaxima Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides BioMaxima's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates BioMaxima's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots BioMaxima's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if BioMaxima grows earnings faster than its peers.

BioMaxima Stock analysis

What does BioMaxima do? BioMaxima is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioMaxima stock

EV/EBIT (Enterprise Value to EBIT) of BioMaxima is 41.83 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — BioMaxima

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — BioMaxima